- Home
- IMNN vs YMAT Comparison
IMNN vs YMAT Comparison
Compare IMNN & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNN | YMAT |
|---|---|---|
| Founded | 1982 | 1970 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 15.3M |
| IPO Year | 1985 | 2025 |
Fundamental Metrics
Financial Performance| Metric | IMNN | YMAT |
|---|---|---|
| Price | $4.20 | $0.85 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $182.61 | N/A |
| AVG Volume (30 Days) | 33.4K | ★ 114.5K |
| Earning Date | 11-13-2025 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $17,563,985.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.92 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.56 | $0.65 |
| 52 Week High | $41.22 | $6.45 |
Technical Indicators
Market Signals| Indicator | IMNN | YMAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.07 | N/A |
| Support Level | $3.83 | N/A |
| Resistance Level | $4.35 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 71.43 | 0.00 |
Price Performance
Historical ComparisonAbout IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.